Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $8.7900 (2.93%) ($8.7900 - $8.7900) on Fri. Jan. 15, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5% (three month average) | RSI | 75 | Latest Price | $8.7900(2.93%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 2.6% a day on average for past five trading days. | Weekly Trend | BCRX advances 6.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(43%) IBB(38%) IWO(38%) IWC(37%) IWM(36%) | Factors Impacting BCRX price | BCRX will decline at least -2.5% in a week (0% probabilities). VIXM(-19%) UUP(-13%) VXX(-8%) IGOV(-4%) TBT(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.5% (StdDev 5%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $8.2(7.2%) | 10 Day Moving Average | $7.91(11.13%) | 20 Day Moving Average | $7.78(12.98%) | To recent high | 0% | To recent low | 74.6% | Market Cap | $1.551b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |